Literature DB >> 3287950

Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans.

U Keller1, P P Gerber, W Stauffacher.   

Abstract

To investigate whether elevated plasma insulin or glucagon concentrations are capable of modifying hepatic ketogenesis independently of plasma free fatty acid (FFA) concentrations, ketone body production was determined by [3-14C]acetoacetate infusions in overnight-fasted normal subjects during exogenous supply of FFA (Intralipid and heparin infusion). When plasma FFA concentrations were elevated from 0.73 +/- 0.07 to 1.53 +/- 0.16 mmol/l during low insulin concentrations (approximately equal to 13 microU/ml) in group A (n = 7), total ketone body production increased from 3.6 +/- 0.6 to 8.2 +/- 1.0 mumol.kg-1.min-1 (P less than 0.001). When plasma FFA were similarly elevated during raised plasma insulin concentrations (approximately equal to 110 microU/ml) in group B (n = 5), total ketone body production was only 3.8 +/- 0.8 mumol.kg-1.min-1 (P less than 0.01 vs. group A). Low plasma FFA and low insulin concentrations resulted in total ketone body production of 0.70 +/- 0.18 mumol.kg-1.min-1 in group C (n = 7; P less than 0.01 vs. groups A and B). Elevation of plasma glucagon during Intralipid infusion in group D (n = 7) failed to affect ketogenesis, but the beta-hydroxybutyrate-to-acetoacetate concentration ratio decreased significantly (P less than 0.01). The data indicate that elevation of plasma insulin to high physiological concentrations restrains FFA-induced ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287950     DOI: 10.1152/ajpendo.1988.254.6.E694

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

2.  The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

Authors:  A Avogaro; A Valerio; L Gnudi; A Maran; M Miola; E Duner; C Marescotti; E Iori; A Tiengo; R Nosadini
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

3.  Increased plasma availability of L-arginine in the postprandial period decreases the postprandial lipemia in older adults.

Authors:  Guilherme M Puga; Christian Meyer; Lawrence J Mandarino; Christos S Katsanos
Journal:  Nutrition       Date:  2012-09-06       Impact factor: 4.008

4.  Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial.

Authors:  Lixin Na; Qiao Zhang; Shuo Jiang; Shanshan Du; Wei Zhang; Ying Li; Changhao Sun; Yucun Niu
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

5.  Circulating lipids in men with type 2 diabetes following 3 days on a carbohydrate-free diet versus 3 days of fasting.

Authors:  Frank Q Nuttall; Rami M Almokayyad; Mary C Gannon
Journal:  Physiol Rep       Date:  2020-10

6.  Biochemical studies in patients with hyperinsulinaemic hypoglycaemia.

Authors:  Hessah Al-Otaibi; Senthil Senniappan; Syeda Alam; Khalid Hussain
Journal:  Eur J Pediatr       Date:  2013-06-12       Impact factor: 3.183

7.  Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients.

Authors:  Jan Gunst; Astrid De Bruyn; Michael P Casaer; Sarah Vander Perre; Lies Langouche; Greet Van den Berghe
Journal:  Crit Care       Date:  2021-10-25       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.